HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Selective adenosine-2 agonist produces both direct and reflex tachycardia in normotensive rats.

Abstract
Hemodynamic responses to intravenous (i.v.) injection of DPMA [N6-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl] adenosine); PD 125,944], a potent adenosine agonist with a 32-fold selectivity for the adenosine-2 (A2) receptor subtype, were characterized in conscious and anesthetized rats. In conscious rats instrumented with miniaturized pulsed-Doppler flow probes, i.v. injection of increasing doses of DPMA (3-30 micrograms/kg) had little effect on mean arterial pressure (MAP, maximal decrease -8 +/- 4 mm Hg) or renal and mesenteric resistance (maximal change 8 +/- 14 and 0 +/- 15%, respectively). In contrast, DPMA markedly reduced MAP (maximal decrease -61 +/- 8 mm Hg) in a dose-dependent (1-30 micrograms/kg) fashion in pentobarbital-anesthetized rats. The A2 agonist also caused a sustained, dose-dependent increase in heart rate (HR, maximal increase 75 +/- 12 beats/min) in conscious rats. The tachycardia and decrease in arterial pressure were completely reversed by i.v. administration of CGS 15943 (250 micrograms/kg), a selective adenosine receptor antagonist. Pretreatment with propranolol or hexamethonium significantly reduced but did not abolish the tachycardia, suggesting that the increase in HR was mediated only partially through reflex increases in sympathetic tone. These data indicate that (a) anesthesia potentiates the depressor actions of DPMA and (b) stimulation of A2 receptors increases HR through both direct and indirect mechanisms of action.
AuthorsR W Lappe, J H Sheldon, B F Cox
JournalJournal of cardiovascular pharmacology (J Cardiovasc Pharmacol) Vol. 19 Issue 3 Pg. 460-3 (Mar 1992) ISSN: 0160-2446 [Print] United States
PMID1378130 (Publication Type: Journal Article)
Chemical References
  • Adrenergic beta-Antagonists
  • Purinergic Antagonists
  • Quinazolines
  • Receptors, Purinergic
  • Triazoles
  • CGS 24012
  • Adenosine
  • 9-chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine
Topics
  • Adenosine (analogs & derivatives, antagonists & inhibitors, pharmacology)
  • Adrenergic beta-Antagonists (pharmacology)
  • Animals
  • Blood Pressure (drug effects)
  • Dose-Response Relationship, Drug
  • Ganglia, Sympathetic (physiology)
  • Heart Rate (drug effects)
  • Male
  • Purinergic Antagonists
  • Quinazolines (pharmacology)
  • Rats
  • Rats, Inbred Strains
  • Receptors, Purinergic (drug effects, physiology)
  • Sympathetic Nervous System (physiology)
  • Triazoles (pharmacology)
  • Vascular Resistance (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: